Valneva SE VALN
NASDAQ VALN
$5.74 -0.16 (-2.71%)
At close: Oct 2, 2026 · 4:00 PM EDT

Valneva SE (VALN) Liabilities from Discontinued Operations (2023)

Updated

Valneva SE (VALN) recorded Liabilities from Discontinued Operations of $1.55 million in Q2 2023.

Analysis

Valneva SE (VALN) Liabilities from Discontinued Operations (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Valneva SE 498.06 Mn -61.83 Mn 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.55 Mn
API Access

Valneva SE Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=VALN&period=max&api_key=YOUR_API_KEY